Cholangiocarcinoma (CCA) is a malignant neoplasm that arises from the biliary tract epithelia. CCA is the second most common primary liver tumour after hepatocellular carcinoma, representing 10-25% of primary hepatic malignancies (1). CCA is rare in many parts of the world, such as Europe and the United States (US), accounting for <3% of all malignant tumours. However, there is a dramatic geographic variation in its incidence, which reflects regional differences in risk factors and epidemiology (2,3).
Tariciotti, L., Lenci, I., Baiocchi, L. (2012). Cholangiocarcinoma: Challenges and future needs. TRANSLATIONAL GASTROINTESTINAL CANCER, 1(1) [10.3978/j.issn.2224-4778.2011.12.07].
Cholangiocarcinoma: Challenges and future needs
BAIOCCHI, LEONARDO
2012-04-01
Abstract
Cholangiocarcinoma (CCA) is a malignant neoplasm that arises from the biliary tract epithelia. CCA is the second most common primary liver tumour after hepatocellular carcinoma, representing 10-25% of primary hepatic malignancies (1). CCA is rare in many parts of the world, such as Europe and the United States (US), accounting for <3% of all malignant tumours. However, there is a dramatic geographic variation in its incidence, which reflects regional differences in risk factors and epidemiology (2,3).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
